Literature DB >> 10500251

cDNA cloning, expression and chromosomal localization of the mouse mitochondrial thioredoxin reductase gene(1).

A Miranda-Vizuete1, A E Damdimopoulos, G Spyrou.   

Abstract

Cytosolic thioredoxin (Trx) and thioredoxin reductase (TrxR) comprise a ubiquitous system that uses the reducing power of NADPH to act as a general disulfide reductase system as well as a potent antioxidant system. Human and rat mitochondria contain a complete thioredoxin system different from the one present in the cytosol. The mitochondrial system is involved in the oxidative stress protection through a mitochondrial thioredoxin-dependent peroxidase. We report here the cDNA cloning and chromosomal localization of the mouse mitochondrial thioredoxin reductase gene (TrxR2). The mouse TrxR2 cDNA encodes for a putative protein of 527 amino acid residues with a calculated molecular mass of 57 kDa, that displays high homology with the human and rat counterparts. The N-terminus of the protein displays typical features of a mitochondrial targeting sequence with absence of acidic residues and abundance of basic residues. Mouse TrxR2 also contains a stop codon in frame at the C-terminus of the protein, necessary for the incorporation of selenocysteine that is required for enzymatic activity. The typical stem-loop structure (SECIS element) that drives the incorporation of selenocysteine is identified in the 3'-UTR. Northern analysis of the mouse TrxR2 mRNA shows a similar pattern of expression with the human homologue, with higher expression in liver, heart and kidney. Finally, we have assigned the mouse TrxR2 gene to chromosome 16 mapping at 11.2 cM from the centromer and linked to the catechol-o-methyltransferase (comt) gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500251     DOI: 10.1016/s0167-4781(99)00129-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function.

Authors:  Marcus Conrad; Cemile Jakupoglu; Stéphanie G Moreno; Stefanie Lippl; Ana Banjac; Manuela Schneider; Heike Beck; Antonis K Hatzopoulos; Ursula Just; Fred Sinowatz; Wolfgang Schmahl; Kenneth R Chien; Wolfgang Wurst; Georg W Bornkamm; Markus Brielmeier
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 3.  The human selenoproteome: recent insights into functions and regulation.

Authors:  M A Reeves; P R Hoffmann
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

4.  The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice.

Authors:  Larisa Nonn; Ryan R Williams; Robert P Erickson; Garth Powis
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 5.  Redox compartmentalization in eukaryotic cells.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Biochim Biophys Acta       Date:  2008-01-26

6.  Genomic organisation and alternative splicing of mouse and human thioredoxin reductase 1 genes.

Authors:  S A Osborne; K F Tonissen
Journal:  BMC Genomics       Date:  2001-11-22       Impact factor: 3.969

7.  Why is mammalian thioredoxin reductase 1 so dependent upon the use of selenium?

Authors:  Adam P Lothrop; Gregg W Snider; Erik L Ruggles; Robert J Hondal
Journal:  Biochemistry       Date:  2014-01-15       Impact factor: 3.162

8.  Structural analysis of glutaredoxin domain of Mus musculus thioredoxin glutathione reductase.

Authors:  Olena Dobrovolska; Elena Shumilina; Vadim N Gladyshev; Alexander Dikiy
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

Review 9.  Mitochondrial Redox Signaling and Tumor Progression.

Authors:  Yuxin Chen; Haiqing Zhang; Huanjiao Jenny Zhou; Weidong Ji; Wang Min
Journal:  Cancers (Basel)       Date:  2016-03-25       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.